3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Unknown
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Genitourinary
1
Conditions
Multiple Myeloma
166
Precursor Cell Lymphoblastic Leukemia-Lymphoma
47
Lymphoma
23
Neoplasms, Plasma Cell
21
Leukemia
21
Recurrence
20
Burkitt Lymphoma
18
Lymphoma, Non-Hodgkin
15
Neoplasms
14
Lymphoma, Mantle-Cell
14
Immunoglobulin Light-chain Amyloidosis
14
Nausea
13
Lymphoma, Large B-Cell, Diffuse
13
Vomiting
12
Breast Neoplasms
12
Hodgkin Disease
11
Waldenstrom Macroglobulinemia
10
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
9
Lymphoma, Follicular
9
Amyloidosis
9
Lymphoma, B-Cell, Marginal Zone
8
Leukemia, Myeloid, Acute
8
Smoldering Multiple Myeloma
7
Neoplasm Metastasis
7
Leukemia, Biphenotypic, Acute
6
Hematologic Neoplasms
6
Blast Crisis
6
Prostatic Neoplasms
5
Lymphoma, T-Cell, Cutaneous
5
Lymphoma, B-Cell
5
Interventions
Gemcitabine
87
Cisplatin
66
Cystectomy
38
pembrolizumab
34
Docetaxel
25
Nivolumab
24
durvalumab
21
Paclitaxel
19
Magnetic Resonance Spectroscopy
18
Radiotherapy
17
Mitomycin
17
Carboplatin
16
atezolizumab
15
Doxorubicin
14
Cystoscopy
14
BCG Vaccine
13
Surveys and Questionnaires
12
Standard of Care
12
avelumab
11
Sunitinib
10
tremelimumab
9
Transurethral Resection of Bladder
9
Ipilimumab
9
Filgrastim
9
Blood Specimen Collection
9
Specimen Handling
8
Neoadjuvant Therapy
8
Methotrexate
8
Methods
8
Early Intervention, Educational
8
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER
×
Urinary Bladder Neoplasms
×
Calcium Dobesilate
×
Clear all
NCT03193788
2017-06-21
PREMIER
Asan Medical Center
Phase 3
Unknown
74 enrolled